4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-010336
Chairman and CEO bought 22,750 shares at an average $1.82 ($41,315)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-02-13 | Purchase | +5,050 | $1.80 | $9,090 | 10,342,843 | D |
| Niihara Yutaka Chairman and CEO | 2020-02-14 | Purchase | +13,700 | $1.85 | $25,345 | 10,356,543 | D |
| Niihara Yutaka Chairman and CEO | 2020-02-18 | Purchase | +4,000 | $1.72 | $6,880 | 10,360,543 | D |
| Open-market purchases · 22,750 sh · avg $1.82 · $41,315 | |||||||
Loading xslF345X03/doc4.xml…